Global /South Korea /Healthcare /Medical Devices /303360

Protia Inc.

303360

• KRX: 303360 • Delayed

4,940KRW -1%

3.25 USD

As of 14 June 2026, Protia Inc. has a market cap of $41.83M USD, ranking #31827 globally and #1873 in South Korea. It ranks #2874 in the Healthcare sector, and #593 in the Medical Devices industry.

Global Rank

31827

Country Rank

1873

Sector Rank

2874

Industry Rank

593

Key Stats

Market Cap

$41.83MUSD

63.61B KRW

Enterprise Value

$33.09MUSD

50.23B KRW

Revenue (TTM)

$9.94MUSD

15.12B KRW

EBITDA (TTM)

$2.76MUSD

4.19B KRW

Net Income (TTM)

$2.94MUSD

4.47B KRW

EBITDA Margin

28%

Profit Margin

30%

PE Ratio

14.2

PS Ratio

4.2

PB Ratio

2.1

EV/EBITDA

12.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Kook Jin Lim open_in_new

Founded

2000

Website

protia.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	1.5%	5.3%	-9.8%	4%	-20%	53%	-36%	-34%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	303360 주식회사 프로티아 Ordinary Shares ISIN: KR7303360002 Shares Out.: Shares Outstanding: 12.88M¹ Shares Float: 7.426M² TV: TradingView: KRX: 303360 SA: Stock Analysis: KRX: 303360 YF: Yahoo Finance: 303360.KS GF: Google Finance: KRX: 303360 BA: Barron's: 303360 MS: Morningstar: XKRX: 303360	4,940 KRW	TV: TradingView: KRX: 303360 SA: Stock Analysis: KRX: 303360 YF: Yahoo Finance: 303360.KS GF: Google Finance: KRX: 303360 BA: Barron's: 303360 MS: Morningstar: XKRX: 303360

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Protia Inc.

Protia Inc. manufactures and sells in vitro diagnostic medical devices in South Korea. It offers allergy, animal diagnosis, autoimmune, antibiotic susceptibility, POCT, cancer, and related instrument products, as well as protein analysis, LC-MS/MS, characterization analysis, and custom protein services. The company was formerly known as ProteomeTech Inc. and changed its name to Protia Inc. in November 2023. Protia Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.47B 3.75T KRW 6K%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.23B 1.86T KRW 3K%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.19B 1.81T KRW 3K%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.14B 1.74T KRW 3K%	-	South Korea
Seegene, Inc. KRX: 096530	$759.58M 1.16T KRW 2K%	23.9	South Korea
i3system Inc. KRX: 214430	$532.37M 809.64B KRW 1K%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 414K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 384K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 380K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 302K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 288K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 244K%	22.2	Ireland

chevron_leftBack